FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer

FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer

<b>Background:</b> Albumin-bound paclitaxel (nab-PTX) nanoparticles have been proven effective in treating advanced pancreatic cancer. However, the clinical application of nab-PTX nanoparticles is often associated with suboptimal outcomes and severe side effects due to its non-specific d...

Full description

Saved in:
Bibliographic Details
Main Authors: Jian Wang, Nianhui Yu, Yunpeng Tang, Yingsheng Cheng, Hui Li
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pharmaceuticals
Subjects:
pancreatic cancer
chemotherapy
sonodynamic therapy
thermosensitive hydrogel
Online Access:https://www.mdpi.com/1424-8247/17/12/1666
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items